Pulsar Clinical Technologies, Inc.

Cambridge, MA 02138

SBIR Award Summary

Total Number of Awards 6
Total Value of Awards $1.65MM
First Award Date 02/11/05
Most Recent Award Date 08/01/09

Key Personnel

Last Name Name Awards Contact
Awdeh Zuheir L Awdeh 6

6 Awards Won

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-07-280
Budget: 08/01/09 - 07/31/11

DESCRIPTION (provided by applicant): This SBIR project addresses an important medical need for improved, new technology-based assays for detecting autoantibodies relevant to Type 1 diabetes (T1D). T1D affects a million Americans and its incidence is increasing at an alarming rate of 2 to 5% per year. In T1D, circulating autoantibodies against i...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-07-80
Budget: 08/28/08 - 07/31/09

DESCRIPTION (provided by applicant): This SBIR project addresses an important medical need for improved, new technology-based assays for detecting autoantibodies relevant to Type 1 diabetes (T1D). T1D affects a million Americans and its incidence is increasing at an alarming rate of 2 to 5% per year. In T1D, circulating autoantibodies against i...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-07-80
Budget: 02/15/08 - 07/31/09

DESCRIPTION (provided by applicant): Worldwide, TB causes more human deaths than any other infectious disease and most of these deaths occur in developing countries where access to improved diagnostic tools is lacking. The key to controlling the TB epidemic is the early identification and treatment of patients with latent disease before conversi...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-06-20
Budget: 07/01/07 - 06/30/08

DESCRIPTION (provided by applicant): This SBIR project addresses an important medical need for improved, new technology-based assays for detecting auto antibodies relevant to Type I Diabetes (T1D). T1D affects a million Americans and its incidence is increasing at an alarming rate of 2 to 5% per year. In T1D, circulating auto antibodies against ...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 02/01/06 - 01/31/08

DESCRIPTION (provided by applicant): Bone marrow transplantation is a preferred clinical treatment for an expanding number of diseases. Donors and recipients of bone marrow are matched based on a complex group of cell surface proteins called the HLA (Human Leukocyte Antigen) system. While HLA class I A and B and HLA class II DRB1 are believed to...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 02/11/05 - 01/31/06

DESCRIPTION (provided by applicant): Bone marrow transplantation is a preferred clinical treatment for an expanding number of diseases. Donors and recipients of bone marrow are matched based on a complex group of cell surface proteins called the HLA (Human Leukocyte Antigen) system. While HLA class I A and B and HLA class II DRB1 are believed to...